Pentafuside shows anti-HIV activity.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000077560:Enfuvirtide; D015700:HIV Envelope Protein gp41; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D017387:Investigational New Drug Application; D051379:Mice; D010446:Peptide Fragments; D012106:Research; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide